cp wire

CP Wire Articles

NANOBIOTIX Achieves Primary and Secondary Endpoints in Ph II/III Study in Soft Tissue Sarcoma with NBTXR3
  • Primary endpoint was the pathological Complete Response Rate
  • The main secondary endpoint was the resection margin status evaluating the quality of surgery
  • NBTXR3 accumulates... read more
Fri, 06/22/18 - 10:09 am
The Latest Biotech IPO - $150 million

Autolus Therapeutics plc (“Autolus”) announced on 6/22/2018 the pricing of its initial public offering in the United States of 8,823,530 American Depositary Shares (“ADSs”) representing 8,823,530... read more

Fri, 06/22/18 - 09:41 am
Machine Learning Platform that Predicts Sepsis Goes Live

Phelps Hospital has launched Dascena’s InSight algorithm house wide. InSight is a machine learning platform built for accurate sepsis onset predictions using only vital signs in the hospital’s EHR... read more

Thu, 06/21/18 - 05:19 pm
Phase III Trial Data Demonstrates Significant Overall Survival Benefit of Lonsurf (trifluridine and tipiracil) in Patients with Metastatic Gastric Cancer


Servier and Taiho Pharmaceutical Co., Ltd. Announced on 6/21/2-18 clinical data from the pivotal Phase III trial (TAGS) for Lonsurf (trifluridine and tipiracil, TAS-102) which showed... read more

Thu, 06/21/18 - 09:53 am
Heron's HTX-011 for Postoperative Pain Management Receives Breakthrough Therapy Designation from FDA
  • Combination of local anesthetic bupivacaine and anti-inflam meloxicam
  • Applied directly to site of injury
  • Company expects to submit NDA in second half of 2018

... read more

Thu, 06/21/18 - 09:17 am

Pages